Elan Targeted In Off-Label Marketing Probe
Irish pharmaceutical company Elan Corp. is facing a kickback probe from the U.S. Department of Justice and the Department of Health over the promotion of epilepsy drug Zonegran for off-label uses....To view the full article, register now.
Already a subscriber? Click here to view full article